The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
the placebo got just GP 100 which is just a cancer vaccine by the way this is a cancer vaccine that never showed any efficacy so it was a cancer vaccine that had been tested both with interlukin 2 directly and um as an adant for patients who had metastatic melanoma or had sorry not metastatic melanoma who had melanoma reected who were tumor free and then given the vaccine as adant to see did that have an effect on outcomes and it didn't
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
I think you're referring obviously to the GP 100 and I think the thing thinking was okay it hasn't been effective in other treatments for example when combined with I2 or as an adant but never before has it been tried with a checkpoint inhibitor which is the technical term for this type of drug
Whole-body MRI screening in healthy adults produces more incidentaloma harm than cancer-mortality benefit.
Starting colonoscopy screening at 45 (vs 50) prevents enough early-onset cancers to justify the population cost.
Multi-cancer liquid-biopsy tests like Galleri detect early cancers at a stage that meaningfully improves survival.